A detailed history of Federation Des Caisses Desjardins Du Quebec transactions in Edwards Lifesciences Corp stock. As of the latest transaction made, Federation Des Caisses Desjardins Du Quebec holds 264,860 shares of EW stock, worth $19.6 Million. This represents 0.09% of its overall portfolio holdings.

Number of Shares
264,860
Previous 263,370 0.57%
Holding current value
$19.6 Million
Previous $24.3 Million 28.15%
% of portfolio
0.09%
Previous 0.14%

Shares

30 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Nov 13, 2024

BUY
$59.7 - $93.78 $88,953 - $139,732
1,490 Added 0.57%
264,860 $17.5 Million
Q2 2024

Aug 14, 2024

BUY
$84.3 - $94.31 $113,552 - $127,035
1,347 Added 0.51%
263,370 $24.3 Million
Q1 2024

May 15, 2024

BUY
$72.54 - $95.56 $19 Million - $25 Million
262,023 New
262,023 $25 Billion
Q4 2023

Aug 14, 2024

SELL
$61.71 - $77.76 $1.29 Million - $1.62 Million
-20,874 Reduced 8.15%
235,291 $17.9 Billion
Q3 2023

Aug 14, 2024

BUY
$69.28 - $93.38 $349,240 - $470,728
5,041 Added 2.01%
256,165 $17.7 Billion
Q2 2023

Aug 14, 2024

BUY
$81.41 - $94.33 $15.4 Million - $17.8 Million
188,938 Added 303.83%
251,124 $23.7 Billion
Q1 2023

Aug 14, 2024

SELL
$74.26 - $84.51 $889,931 - $1.01 Million
-11,984 Reduced 16.16%
62,186 $5.14 Billion
Q4 2022

Aug 14, 2024

SELL
$68.3 - $87.44 $276,888 - $354,481
-4,054 Reduced 5.18%
74,170 $5.53 Billion
Q3 2022

Aug 14, 2024

SELL
$82.37 - $107.29 $26,358 - $34,332
-320 Reduced 0.41%
78,224 $6.46 Billion
Q2 2022

Aug 14, 2024

BUY
$86.5 - $128.27 $375,410 - $556,691
4,340 Added 5.85%
78,544 $7.47 Billion
Q1 2022

Aug 14, 2024

SELL
$101.96 - $128.34 $19.3 Million - $24.3 Million
-189,166 Reduced 71.83%
74,204 $8.74 Billion
Q4 2021

Aug 30, 2024

BUY
$106.37 - $130.68 $617,371 - $758,466
5,804 Added 9.25%
68,566 $8.88 Billion
Q3 2021

Aug 30, 2024

SELL
$102.91 - $122.75 $3.04 Million - $3.63 Million
-29,577 Reduced 32.03%
62,762 $7.1 Billion
Q2 2021

Aug 30, 2024

SELL
$83.84 - $104.76 $14.3 Million - $17.9 Million
-171,031 Reduced 64.94%
92,339 $9.56 Billion
Q1 2021

Aug 30, 2024

BUY
$78.68 - $90.67 $6.17 Million - $7.11 Million
78,424 Added 785.89%
88,403 $7.39 Billion
Q4 2020

Aug 30, 2024

BUY
$71.69 - $91.23 $355,439 - $452,318
4,958 Added 98.75%
9,979 $911 Million
Q3 2020

Aug 30, 2024

BUY
$67.19 - $87.44 $52,139 - $67,853
776 Added 18.28%
5,021 $401 Million
Q2 2020

Aug 30, 2024

BUY
$57.54 - $76.95 $153,171 - $204,840
2,662 Added 168.16%
4,245 $293 Million
Q1 2020

Aug 30, 2024

SELL
$52.41 - $81.0 $4,192 - $6,480
-80 Reduced 4.81%
1,583 $299 Million
Q4 2019

Aug 30, 2024

BUY
$71.7 - $82.09 $12,690 - $14,529
177 Added 11.91%
1,663 $388 Million
Q3 2019

Aug 30, 2024

SELL
$61.55 - $75.43 $492 - $603
-8 Reduced 0.54%
1,486 $327 Million
Q2 2019

Aug 30, 2024

BUY
$55.74 - $64.41 $8,751 - $10,112
157 Added 11.74%
1,494 $276 Million
Q1 2019

Aug 30, 2024

SELL
$47.89 - $64.05 $30,314 - $40,543
-633 Reduced 32.13%
1,337 $256 Million
Q4 2018

Aug 30, 2024

SELL
$46.41 - $56.94 $12.1 Million - $14.9 Million
-261,400 Reduced 99.25%
1,970 $302 Million
Q3 2018

Aug 30, 2024

BUY
$45.7 - $58.03 $3,427 - $4,352
75 Added 2.43%
3,161 $550 Million
Q2 2018

Aug 30, 2024

BUY
$42.45 - $51.3 $9,975 - $12,055
235 Added 8.24%
3,086 $449 Million
Q1 2018

Aug 30, 2024

BUY
$37.19 - $47.45 $5,950 - $7,592
160 Added 5.95%
2,851 $398 Million
Q4 2017

Aug 30, 2024

BUY
$33.79 - $39.39 $55,246 - $64,402
1,635 Added 154.83%
2,691 $303 Million
Q2 2017

Aug 30, 2024

SELL
N/A
-27 Reduced 2.49%
1,056 $125 Million
Q1 2017

Aug 30, 2024

SELL
N/A
-262,287
1,083 $102 Million

Others Institutions Holding EW

About Edwards Lifesciences Corp


  • Ticker EW
  • Exchange NYSE
  • Sector Healthcare
  • Industry Medical Devices
  • Shares Outstandng 618,259,968
  • Market Cap $45.7B
  • Description
  • Edwards Lifesciences Corporation provides products and technologies for structural heart disease, and critical care and surgical monitoring in the United States, Europe, Japan, and internationally. It offers transcatheter heart valve replacement products for the minimally invasive replacement of heart valves; and transcatheter heart valve repair...
More about EW
Track This Portfolio

Track Federation Des Caisses Desjardins Du Quebec Portfolio

Follow Federation Des Caisses Desjardins Du Quebec and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Federation Des Caisses Desjardins Du Quebec, based on Form 13F filings with the SEC.

News

Stay updated on Federation Des Caisses Desjardins Du Quebec with notifications on news.